The prognostic significance of p53, p21(Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients

Anticancer Research

Volumn 19, Issue 5 C, 1999, Pages 4587-4591

  Hirai, Toshihiro ^a   Kuwahara, Masaki ^a   Yoshida, Kazuhiro ^a   Osaki, Akihiko ^a   Toge, Tetsuya ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cyclin D1; Esophageal cancer; p21(Waf1 Cip1); p53

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLIN D1; ONCOPROTEIN; PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033452653     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Takamura H, Fushida S, Hashimoto T, Yagi M, Miyazaki I: Analysis of the p16INK4, p15INK4B genes abnormality and the amplification of cyclin D1 gene in esophageal cancer. Nippon Rinshou 54: 1043-1048, 1996.
2. Zhou P, Jiang W, Zhang YJ, Kahn SM, Schieren I, Santella RM, Weinstein IB : Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 11: 571-580, 1995.
3. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T: Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 146: 1161-1169, 1995.
4. Mukaida H, Toi M, Hirai T, Yamashita Y, Toge T: Clinical significance of the expression of epidermal growth factor and its receptor in esophageaol cancer. Cancer 68: 142-148, 1991.
5. Japanese Society for Esophageal Diseases: Guidelines for the clinical and pathological studies on carcinoma of the esophagus (8th edn.). Tokyo, Kanehara Shuppan, 1992.
6. Hirai T, Yamashita Y, Mukaida H, Kuwahara M, Inoue H, Toge T: Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today 28: 576-579, 1998.
7. Ikeguchi M, Saito H, Katano K, Kondou A, Tsujitani S, Maeta M, Kaibara N: Radiochemosensitivity and expression of p53 in patients with esophageal cancer treated by absolute noncurative resection. Anticancer Res 18: 493-497, 1998.
8. Seta T, Imazeki F, Sokosuka O, Saisho H, Suzuki T, Koide Y, Isono K: Expression of p53 and p21Waf1/Cip1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene. Dig Dis Sci 43: 279-289, 1998.
9. Yang G, Zhang Z, Liao J, Seril D, Wang L, Goldstein S, Yang CS: Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in nothern China. Int J Cancer 72: 746-751, 1997.
10. Ikeguchi M, Saito H, Katano K, Tsujitani S, Maeta M, Kaibara N: Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma. J Am Coll Surg 185: 398-403, 1997.
11. Bosari S, Viale G: The clinical significance of p53 aberrations in human tumors. Virchow Arch 427: 229-241, 1995.
12. Chaves P, Pereira AD, Pinto A, Oliveira AG, Queimado L, Gloria L, Cardoso P, Mira FC, Soares J: p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium. J Surg Oncol 65: 3-9, 1997.
13. Kuwano H, Watanabe M, Sadanaga N, Kamakura T, Nozoe T, Yasuda M, Mimori K, Mori M, Sigimachi K: Univariate and multivariate analysis of the prognostic significance of discontinuous intramural metastasis in patients with esophageal cancer. J Surg Oncol 57: 17-21, 1994.
14. Kolh P, Honore P, Degauque C, Azzam C, Gielen JL, Legrand M, Dewe W, Jacquet N: Surgery of esophageal cancer in Liege. II. Analysis of factors influencing long-term survival after esophagectomy for epidermoid cancer or adenocarcinoma. Rev Med Liege 53: 363-369, 1998.
15. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE: p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74: 2218-2223, 1994.
16. Hirai T, Kuwahara M, Yushida K, Kagawa Y, Hihara J, Yamashita Y, Toge T: Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markers. Diseases of the esophagus 11: 221-225, 1998.
17. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
18. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a protein mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
19. Doki Y, Imoto M, Han EK, Sgambato A, Weinstein IB: Increased expression of the p27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis 18: 1139-1148, 1997.